Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| KL1-M52H9 | Mouse | Mouse Plasma Kallikrein / KLKB1 Protein, His Tag |  |
|
|
| KL1-H52H9 | Human | Human Plasma Kallikrein / KLKB1 Protein, His Tag (active enzyme, MALS verified) |  |
|
The purity of Human Plasma Kallikrein/KLKB1, His Tag (Cat. No. KL1-H52H9) is more than 90% and the molecular weight of this protein is around 75-90 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Lanadelumab | 2372V1TKXK (UNII code); X124-G01; SHP-643; DX-2930; TAK-743 | Approved | Dyax Pharma | Takhzyro, 达泽优 | United States | Angioedemas, Hereditary | Dyax Corp | 2018-08-23 | Drug-Related Side Effects and Adverse Reactions; Hypotension; Coronavirus Disease 2019 (COVID-19); Hereditary Autoinflammatory Diseases; Angioedema; Angioedemas, Hereditary; Lung Injury | Details |
| Berotralstat | BCX-7353 | Approved | Biocryst Pharmaceuticals Inc | ORLADEYO | United States | Angioedemas, Hereditary | Biocryst Pharmaceuticals Inc | 2020-12-03 | Angioedemas, Hereditary | Details |
| Ecallantide | DX-88; EPI-KAL2; FOV-2302; CB-500929 | Approved | Dyax Pharma | Kalbitor | United States | Angioedema | Dyax Corp | 2009-12-01 | Macular Edema; Hereditary Angioedema Types I and II; Blood Loss, Surgical; Angioedemas, Hereditary; Retinal Vein Occlusion; Angioedema | Details |
| Lanadelumab | 2372V1TKXK (UNII code); X124-G01; SHP-643; DX-2930; TAK-743 | Approved | Dyax Pharma | Takhzyro, 达泽优 | United States | Angioedemas, Hereditary | Dyax Corp | 2018-08-23 | Drug-Related Side Effects and Adverse Reactions; Hypotension; Coronavirus Disease 2019 (COVID-19); Hereditary Autoinflammatory Diseases; Angioedema; Angioedemas, Hereditary; Lung Injury | Details |
| Berotralstat | BCX-7353 | Approved | Biocryst Pharmaceuticals Inc | ORLADEYO | United States | Angioedemas, Hereditary | Biocryst Pharmaceuticals Inc | 2020-12-03 | Angioedemas, Hereditary | Details |
| Ecallantide | DX-88; EPI-KAL2; FOV-2302; CB-500929 | Approved | Dyax Pharma | Kalbitor | United States | Angioedema | Dyax Corp | 2009-12-01 | Macular Edema; Hereditary Angioedema Types I and II; Blood Loss, Surgical; Angioedemas, Hereditary; Retinal Vein Occlusion; Angioedema | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Sebetralstat | KVD-900 | Phase 3 Clinical | Kalvista Pharmaceuticals | Angioedemas, Hereditary | Details |
| THR-149 | TG-758; THR-149 | Phase 2 Clinical | Bicycle Therapeutics, Thrombogenics Inc | Diabetic macular oedema; Diabetic Retinopathy; Diabetes Mellitus | Details |
| QLS-215 | QLS-215; STAR-0215 | Phase 2 Clinical | Quellis Biosciences Inc | Angioedemas, Hereditary | Details |
| NTLA-2002 | NTLA-2002 | Phase 2 Clinical | Intellia Therapeutics Inc | Angioedemas, Hereditary | Details |
| KVD-001 | KVD-001 | Phase 2 Clinical | Vantia Ltd | Diabetic macular oedema | Details |
| MDPK-67b | DM-107; MDPK-67b; MDPK-67 | Phase 1 Clinical | Med Discovery | Prostatic Neoplasms | Details |
| Feniralstat | KVD-824 | Phase 1 Clinical | Vantia Ltd | Hereditary Angioedema Types I and II; Angioedemas, Hereditary | Details |
| MSB-03 | MSB-03 | Phase 1 Clinical | Rosacea | Details | |
| ATN-249 | ATN-249 | Phase 1 Clinical | Attune Pharmaceuticals | Angioedemas, Hereditary | Details |
| Sebetralstat | KVD-900 | Phase 3 Clinical | Kalvista Pharmaceuticals | Angioedemas, Hereditary | Details |
| THR-149 | TG-758; THR-149 | Phase 2 Clinical | Bicycle Therapeutics, Thrombogenics Inc | Diabetic macular oedema; Diabetic Retinopathy; Diabetes Mellitus | Details |
| QLS-215 | QLS-215; STAR-0215 | Phase 2 Clinical | Quellis Biosciences Inc | Angioedemas, Hereditary | Details |
| NTLA-2002 | NTLA-2002 | Phase 2 Clinical | Intellia Therapeutics Inc | Angioedemas, Hereditary | Details |
| KVD-001 | KVD-001 | Phase 2 Clinical | Vantia Ltd | Diabetic macular oedema | Details |
| MDPK-67b | DM-107; MDPK-67b; MDPK-67 | Phase 1 Clinical | Med Discovery | Prostatic Neoplasms | Details |
| Feniralstat | KVD-824 | Phase 1 Clinical | Vantia Ltd | Hereditary Angioedema Types I and II; Angioedemas, Hereditary | Details |
| MSB-03 | MSB-03 | Phase 1 Clinical | Rosacea | Details | |
| ATN-249 | ATN-249 | Phase 1 Clinical | Attune Pharmaceuticals | Angioedemas, Hereditary | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
